Abbott in $385M settlement with DOJ over infant formula recall
Reported by Seeking Alpha · seekingalpha.com ·
Story context
What to watch: Abbott Laboratories (ABT) faces a legal or regulatory issue — headline risk here is often larger than the eventual financial impact.
Latest session change: $ABT +1.12%
- $ABT earningsWed, Oct 14 · in 30 daysAbbott Laboratories
- $ABT earningsWed, Oct 21 · in 37 daysAbbott Laboratories
Confirmed dates for the names in this story. Listed because they are scheduled, not because this story affects them.
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures come from the published headline or preview. Session moves may include other news and do not establish cause.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.